NRAS and RASopathy: In mosaic RASopathies, NRAS p.Q61R mutations have been identified in a patient with Schimmelpenning syndrome [19], patients with neurocutaneous melanosis [20], and patients with cutaneous–skeletal hypophosphatemia syndrome [21].